Circulating Fibroblast Activation Protein as Potential Biomarker in Patients With Inflammatory Bowel Disease

Circulating Fibroblast Activation Protein as Potential Biomarker in Patients With Inflammatory Bowel Disease

A major concern in the management of Inflammatory Bowel Disease (IBD) is the absence of accurate and specific biomarkers to drive diagnosis and monitor disease status timely and non-invasively. Fibroblast activation protein (FAP) represents a hallmark of IBD bowel strictures, being overexpressed in...

Full description

Bibliographic Details
Main Authors: Fabio Corsi, Luca Sorrentino, Sara Albasini, Francesco Colombo, Maria Cigognini, Alessandro Massari, Carlo Morasso, Serena Mazzucchelli, Francesca Piccotti, Sandro Ardizzone, Gianluca M. Sampietro, Marta Truffi
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Medicine
Subjects:
inflammatory bowel disease
fibroblast activation protein
blood biomarkers
diagnosis
mucosal healing
chronic patient
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.725726/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2021.725726/full

Similar Items